Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Treovir & Matica Bio Partner on Pediatric Brain Tumor Therapies Development
Details : The collaboration aims to advance G207 HSV-based oncolytic therapy for pediatric patients with brain and other neurological cancers.
Product Name : G207
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
April 12, 2024